ClinicalTrials.Veeva

Menu

Magnitude of Osteoarthritis disadVantage on pEoples liveS (MOVES)

AstraZeneca logo

AstraZeneca

Status

Completed

Conditions

Osteoarthritis

Study type

Observational

Funder types

Industry

Identifiers

NCT01423097
NIS-RPO-XXX-2011/2

Details and patient eligibility

About

Estimate the prevalence of self-reported osteoarthritis and its characterization in adults over 45 years of age:

  • Characterization of self-reported patients with OA (socio-demographic, comorbidities, VAS for intensity of pain)
  • Characterization of OA diagnosis in patients with self-reported OA
  • Impact of self-reported OA in the working abilities, quality of life and functionality (SF-12 v2.0)
  • Characterization of treatment approaches (therapeutic and non-therapeutic) for self-reported patients with OA
  • Patient perception of impact of OA in its life and importance given to disease

Full description

Magnitude of Osteoarthritis disadvantage on peoples lives.

Enrollment

1,015 patients

Sex

All

Ages

45+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Adults over 45 years old with self-reported osteoarthritis

Exclusion criteria

  • NA

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems